Source: Annual Congress 2002 - Cystic fibrosis: new science, new epidemiology, new problems
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Barker, D. Thoenes, C. Pfannenstiel, H. Doehmen, F. Friedrichs, M. Buchenroth, G. Heimann (Aachen, Aachen-Laurensberg, Germany). Prevalence of thrombophilia and catheter-related events in cystic fibrosis. Eur Respir J 2002; 20: Suppl. 38, 2123

Member's Comments

No comment yet.

Related content which might interest you: Prevalence, risk factors and prognosis of pulmonary hypertension in cystic fibrosis Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge Year: 2011 Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease Source: Eur Respir J 2012; 39: 125-132 Year: 2012 Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease Source: Eur Respir J 2011; 39: 125-132 Year: 2012 Cardiovascular complications of cystic fibrosis Source: Eur Respir Monogr 2020; 88: 108-117 Year: 2020 Thrombophilia in patients with idiopathic pulmonary thromboembolism vs associated with risk factors Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Prevalence of hyperglycaemia during infective exacerbation in adult cystic fibrosis patients Source: Eur Respir J 2007; 30: Suppl. 51, 387s Year: 2007 Impact of co-morbidities on disease severity and risk of mortality in non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 Candidaemia in cystic fibrosis patients with totally implantable venous access devices is associated with invasive procedures and exacerbation frequency Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment Year: 2015 A prothrombotic state is associated with increased mortality in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Predictive factors for severe pulmonary exacerbations in patients with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 715s Year: 2006 Predictor factors of mortality in patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) Year: 2018 Risk factors for allergic bronchopulmonary aspergillosis in paediatric patients with cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 Early deaths in cystic fibrosis: Analysis of causes and risk factors in a pediatric cohort Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems Year: 2012 Factors associated with recurrence of severe exacerbations in Non-cystic fibrosis bronchiectasis in developping countries. Source: International Congress 2019 – Clinical problems Year: 2019 Is etiology of non-cystic fibrosis bronchiectasis (NCFBE) a risk factor for severe exacerbation? Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Cystic fibrosis a contagious disease. Need for segregation Source: Annual Congress 2005 - Paediatric year in review Year: 2005 The epidemiology and invasive therapy of portal hypertension in cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 127s Year: 2001 Identifying undiagnosed cystic fibrosis in adults with bronchiectasis Source: Eur Respir Monogr 2018; 81: 29-44 Year: 2018 Symptomatic sinus disease and use of antibiotics in cystic fibrosis Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Course of disease and cause of death in patients with idiopathic pulmonary fibrosis in Eastern Finland Source: International Congress 2015 – IPF: clinical aspects Year: 2015